Systematic optimization of PD-L1 and CLDN18.2 CAR-T designs identifies a bicistronic dual-target, double-CD3ζ architecture with enhanced antitumor activity in gastric cancer

Xiang Zhang, Yao-jie Kong, Jing-yao Li, Heng-hui Li, Liang Chen · 2026

Read Systematic optimization of PD-L1 and CLDN18.2 CAR-T designs identifies a bicistronic dual-target, double-CD3ζ architecture with enhanced antitumor activity in gastric cancer by Xiang Zhang, Yao-jie Kong, Jing-yao Li, Heng-hui Li, Liang Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13270025.txt.

Description

Xiang Zhang and co-authors optimize in 2026 engineered T cells that hunt gastric cancer on two targets at once, PD-L1 and a tight-junction protein called CLDN18.2. Single-target cell therapies falter when tumors drop the target or vary between cells. The team built single-target versions with different internal signal parts, compared them, then engineered three dual-target designs that differ in how their signaling tails are arranged.

The design carrying two copies of the main signaling unit expanded better, killed more effectively, and showed stronger immune activation with fewer exhaustion markers in gene profiles. In mice bearing human gastric tumors, it slowed tumor growth clearly more than the best single-target version. The authors present the architecture as a route to more durable cell therapy for solid tumors.

Catalog record

CREATORXiang Zhang, Yao-jie Kong, Jing-yao Li, Heng-hui Li, Liang Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13270025

Browse the full library · About the Tower of Babel